Nanoco Regulatory News (NANO)

12 March 2019

NANOCO GROUP PLC

("Nanoco", the "Company" or the "Group")

Directorate Changes

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from our technology platform, announces the following changes to the membership of the Board.

Brendan Cummins, Non-Executive Director and Chair of the Remuneration Committee, has announced that he wishes to step down from the Board to focus on other commitments which he has recently taken up, particularly in the area of social enterprise.

Dr Alison Fielding has indicated her wish to take over Brendan's responsibility as Chair of the Remuneration Committee, remaining as a member of the Audit Committee and the Nominations Committee. Alison will also assume Brendan's responsibilities as Senior Independent Director

The Company is pleased to announce the appointment of Christopher Batterham to the Board as a Non-Executive Director and Chair of the Audit Committee. Chris will also be a member of the Remuneration Committee and the Nominations Committee.

Chris has considerable financial and operational experience. He qualified as a chartered accountant with Arthur Andersen LLP in 1979 and became the finance director of Unipalm Group plc, from 1996 to 2001. He then went on to become CFO of Searchspace Group Limited from 2001 until 2005. Chris is currently a Non-Executive Director of Blue Prism Group plc and NCC Group plc. Chris holds a Natural Sciences degree from Cambridge University.

Chris Batterham will join the Board on 1 April 2019 and the other Board changes noted above will take effect from 19 April 2019.

Dr Christopher Richards, Chairman, said:

"We are delighted to be joined by Chris who brings a wealth of commercial, financial and operational experience across a range of high growth technology sectors which will be highly relevant to Nanoco in the years ahead. His appointment adds to the breadth of skills and abilities of the Board as we move forward to commercial success. His extensive public company Board experience will also reinforce Nanoco's continued commitment to governance.

The Board would like to thank Brendan for his wise counsel and commitment to the Group over the last four years. We wish him well in the years ahead."

Disclosures required pursuant to Listing Rule 9.6.13

In addition to those companies listed above Chris Batterham has, in the last five years, held directorships in the following publicly quoted companies:

Chris was a director of Manchester Racing Limited at the time it entered into a members' voluntary liquidation in 2003 and was a director of the Mediawave Group Limited when it went into administration and compulsory liquidation in 2003. Chris resigned as director of Conclusive Logic Limited in November 2001, which entered into a creditors' voluntary liquidation in March 2002.

For further information, please contact:

Notes for editors:

Nanoco (LSE: NANO) harnesses the power of nano-materials. Nano-materials are materials with dimensions typically in the range 1 - 100 nm. Nano-materials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nano-material that have size-dependent optical and electronic properties. The Group produces quantum dots. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Display and Electronics markets. One of the interesting properties of quantum dots is photoluminescence: the emission of longer wavelength light upon excitation by light of a shorter wavelength. The colour of light emitted depends on the particle size. Nanoco's CFQD® quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of applications including displays, lighting and biological imaging.

Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany and Wah Hong Industrial Corporation of Taiwan.

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.